VitaNova Life Sciences Corporation

OTCPK:VNOV Stock Report

Market Cap: US$19.8m

VitaNova Life Sciences Past Earnings Performance

Past criteria checks 0/6

VitaNova Life Sciences has been growing earnings at an average annual rate of 54.2%, while the Consumer Retailing industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 74.6% per year.

Key information

54.17%

Earnings growth rate

22.59%

EPS growth rate

Consumer Retailing Industry Growth10.91%
Revenue growth rate74.57%
Return on equity-1.82%
Net Margin-1.23%
Last Earnings Update30 Apr 2026

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How VitaNova Life Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:VNOV Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Apr 263010
31 Jan 263110
31 Oct 253100
31 Jul 253100
30 Apr 253100
31 Jan 251000
31 Oct 241000
31 Jul 241000
30 Apr 241000
31 Jan 240000
31 Oct 230000
31 Jul 230000
30 Apr 230000
31 Jan 230000
31 Oct 220000
31 Jul 220000
30 Apr 220000
31 Jan 220000
31 Oct 210000
31 Jul 210000
30 Apr 210000
31 Jan 210000
31 Oct 200000
31 Jul 200000
30 Apr 200000
31 Jan 200000
31 Oct 190000
31 Jul 190000
30 Apr 190000
31 Jan 190000
31 Oct 180000
31 Jul 180000
30 Apr 180000

Quality Earnings: VNOV is currently unprofitable.

Growing Profit Margin: VNOV is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: VNOV is unprofitable, but has reduced losses over the past 5 years at a rate of 54.2% per year.

Accelerating Growth: Unable to compare VNOV's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VNOV is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (4.6%).

Return on Equity

High ROE: VNOV has a negative Return on Equity (-1.82%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/14 19:17
End of Day Share Price 2026/07/20 00:00
Earnings2026/04/30
Annual Earnings2026/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

VitaNova Life Sciences Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.